Assessment of Right Ventricular Function by 2D Transthoracic Echocardiography in COVID-19 Hospitalized Patient in Correlation with CT Pulmonary Angiographic Findings | ||
| Al-Azhar International Medical Journal | ||
| Volume 2023, Issue 1, January 2023 | ||
| DOI: 10.58675/2682-339X.1698 | ||
| Authors | ||
| Yasser Abd Aljalil Omar1; Ahmed Ali Faheem Abdo2; Ahmed Hameed Edress3 | ||
| 1Assistant Professor of Cardiovascular Diseases Faculty of Medicine - Al-Azhar University | ||
| 2Lecturer of cardiolog, Faculty of Medicine - Al-Azhar University | ||
| 3Faculty of Medicine - Al-Azhar University | ||
| Abstract | ||
| Background: COVID- 19 pandemic outbreak in Egypt began in February 2020 and is still ongoing. For individuals with suspected respiratory symptoms, the Egyptian protocol recommends a non-contrast CT chest. However, many patients with worsening symptoms, particularly in the second week of disease, demonstrated signs of thrombotic events in the pulmonary arteries, which is why CT pulmonary angiography (CTPA) was performed.. Aim of the Work: Evaluation of RV Function by Echocardiography in COVID-19 hospitalized patients in correlation with CT pulmonary angiographic findings Patients and Methods: This study was conducted on One hundred participants attending to the outpatient of Cardiovascular Diseases, Al-Azhar University Hospitals during the time of the study. Results: No statistically significance alterations were seen between the groups in terms of RV basal diameter, FAC, PASP, McConnell’s sign and left ventricular ejection percent, (except for sever pulmonary embolism there is significant reduction in TAPSE parameter) Conclusion: According to our findings, COVID-19 has many potential mechanisms for inducing pulmonary embolism. Furthermore, there was no significant variation in right ventricular dysfunction between the pulmonary embolism and control groups. (except for sever pulmonary embolism there is significant reduction in TAPSE parameter) | ||
|
Statistics Article View: 24 |
||
